Dr. Reddy’s Laboratories’ Q1FY23 Quarter Results

Dr. Reddy’s Laboratories reported 20% YoY revenue growth
  • 28 Jul 2022
  • Dr. Reddy’s Laboratories reported 9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter ended June (Q1FY23). On a year-on-year (YoY) basis, it witnessed a growth of 20%.
  • Its expenses for the quarter were down by 13% QoQ and up by 3% YoY.
  • The pharma major reported a net profit of Rs 1,189 crores in Q1FY23 as against a net profit of Rs 380 crores in Q1FY22.
  • The earnings per share (EPS) of Dr. Reddy’s Laboratories stood at 71.5 during Q1FY23..

Dr. Reddy’s Laboratories’ Financial Statements for Q1FY23:

(Rs, crores) Q1FY22 Q4FY22 Q1FY23 QoQ (%) YoY (%)
Total Income5,0535,5976,0879%20%
Total Expenses4,5145,3484,628-13%3%
Profit before tax5562591,468467%164%
Profit after tax380971,1891126%213%
Earnings per share23.05.871.5

Data Source: BSE, Company announcements

Want to keep a tab on Indian listed companies? Open an account and get daily stock research updates from Kotak Securities.

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Open Demat Account
or Resume your Application
+91 -